Last reviewed · How we verify
NCT03918161
Magnetic Resonance Elastography of Transplanted Kidney (GREFFE_ELASTO IRM)
NA trial testing MRE exam in Interstitial Fibrosis/Tubular Atrophy of Transplanted Kidneys in 73 participants. Completed in 12 December 2020.
10 December 2020
Quick facts
| Lead sponsor | University Hospital, Bordeaux |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 73 |
| Start date | 24 July 2019 |
| Primary completion | 10 December 2020 |
| Estimated completion | 12 December 2020 |
| Sites | 1 location across France |
Drugs / interventions tested
- MRE exam
Conditions studied
- Interstitial Fibrosis/Tubular Atrophy of Transplanted Kidneys — all drugs for Interstitial Fibrosis/Tubular Atrophy of Transplanted Kidneys →
Sponsor
University Hospital, Bordeaux
Who can join
Adults 18 to 65, any sex, with Interstitial Fibrosis/Tubular Atrophy of Transplanted Kidneys. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
: GREFFE\_ELASTO IRM will evaluate Magnetic Resonance Elastography (MRE) in renal transplant patients with suspected interstitial fibrosis/tubular atrophy lesions requiring biopsy graft sampling under ultrasound control. The main objective is to search a correlation between renal graft parenchymal elasticity values obtained in vivo by MRE, and the histological data of renal fibrosis by biopsy sampling, and providing a non-invasive tool capable of detecting and monitoring this development over time, making possible in the future to reduce the number of renal biopsies.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Magnetic Resonance Elastography as Surrogate Marker of Interstitial Fibrosis in Kidney Transplantation: A Prospective Study.
Chauveau B, Merville P, Soulabaille B, Taton B, et al · · 2022 · cited 10× · PMID 36514413 · DOI 10.34067/kid.0004282022
Verify or expand the search:
- PubMed search for NCT03918161
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital, Bordeaux trials
Trials by the same sponsor.
- NCT07506928 — NEURO - Prognostication Using Late Somatosensory Evoked - Potentials · NA · not yet recruiting
- NCT07524036 — Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan. · NA · not yet recruiting
- NCT07527494 — Digital MEDIcal TWIN for the Prediction of Arrhythmic Sudden Cardiac Death After a Myocardial Infarction · NA · not yet recruiting
- NCT07527442 — Efficacy and Safety of Circumcision Alone on Risk of Febrile Urinary Tract Infections in Boys With Posterior Urethral Va · Phase 2 · not yet recruiting
- NCT07478523 — FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03918161 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Bordeaux
- Last refreshed: 26 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03918161.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing